AppLovin reports second-quarter results on August 5 against a striking backdrop: the stock has shed 23% over the past month to $395.90, yet the Street's consensus remains firmly bullish and analyst price targets sit well above where the shares are trading.
The stock's decline is the dominant setup story. AppLovin closed July down nearly a quarter from its prior-month levels, with a modest 1% recovery on the week doing little to offset the damage. Despite the selloff, the borrow market sends a clear message that short sellers are not piling in: availability is extraordinarily loose at 2,625%, meaning there are roughly 26 shares available to borrow for every one already shorted. Cost to borrow has eased further to 0.38%, down sharply on both the week and month. Short interest itself, at 4.1% of the free float, edged up about 7% on the week — a build worth watching, though not yet at levels that dominate the story. Options positioning is equally calm. The put/call ratio of 0.82 sits almost exactly at its 20-day average, with a z-score near zero — no unusual demand for either protection or leverage into the print.
The real tension is between where the stock is and where analysts think it should be. The consensus is unanimously bullish — all 22 tracked analysts carry buy-equivalent ratings — and most targets were set following the Q1 print in early May, when firms including UBS, Macquarie, and JP Morgan all lifted their numbers. Wells Fargo pushed its target modestly higher again in early July. The cluster of targets — ranging from the mid-$500s to $750 — implies 40-90% upside from the current price. Bulls point to AppLovin's AXON ad optimizer, projected 51% revenue growth, expanding EBITDA margins, and an early-stage ecommerce channel showing a 4.4% lift among brands using the Axon Pixel. Bears counter that the stock's year-to-date decline reflects genuine concern: heavy reliance on the gaming unit, an ecommerce segment still finding its footing, and opacity around how long AXON's performance edge can be sustained against a more competitive ad-tech backdrop. JP Morgan's Neutral at a $515 target — while higher than the current price — is notably more cautious than the rest of the pack and reflects lingering valuation skepticism even after the selloff.
The earnings history adds another layer. Two quarters ago, AppLovin fell 7.7% on the day and 18.6% over the following five sessions. The quarter before that, the stock was essentially flat on the day but gained 3.5% across the week. The reaction pattern is asymmetric — the downside prints have hit harder than the upside ones. That context sits alongside a notable institutional flow: Capital Research added 3.7 million shares through June 30, a meaningful buy into weakness, while Fidelity added 2.6 million. CEO Adam Foroughi remains the largest individual holder at nearly 11% of shares, with only a minor trim reported through mid-June.
Wednesday's print is less a test of whether AppLovin can grow and more a test of whether it can demonstrate that AXON's ecommerce expansion has real, reportable momentum — the kind that justifies rebuilding confidence in a stock trading at a 40%-plus discount to where analysts believed it should be just weeks ago.
See the live data behind this article on ORTEX.
Open APP on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
